AusPAR: Xeomin

Australian Public Assessment Report

AusPAR

AusPAR: XEOMIN [PDF, 836.56 KB]

AusPAR: XEOMIN [Word, 1.25 MB]

Attachment Product information for XEOMIN [PDF, 543.39 KB]

Attachment Product information for XEOMIN [Word, 565.99 KB]

Device/Product Name

Xeomin

Active ingredients

incobotulinumtoxinA

AusPAR Date

24 June 2024

Published

3 July 2024

Submission Number

PM-2022-03519-1-1

Submission Type

Extension of indication

Decision

Approved